Albutoin
Appearance
![]() | |
Clinical data | |
---|---|
Other names | BAX-422Z[1] |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C10H16N2OS |
Molar mass | 212.31 g·mol−1 |
3D model (JSmol) | |
|
Albutoin is an anticonvulsant.[1][2] It was marketed in Europe as CO-ORD and Euprax by Baxter Laboratories.[1] It was evaluated by the United States Food and Drug Administration, but not approved.[3]
References
- ^ a b c J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 24–. ISBN 978-1-4757-2085-3.
- ^ Cereghino, J. J.; Brock, J. T.; Van Meter, J. C.; Penry, J. K.; Smith, L. D.; Fisher, P; Ellenberg, J (1974). "Evaluation of albutoin as an antiepileptic drug". Clinical Pharmacology and Therapeutics. 15 (4): 406–16. PMID 4206927.
- ^ Shorvon, Simon D. (2009). "Drug treatment of epilepsy in the century of the ILAE: The second 50 years, 1959-2009". Epilepsia. 50: 93–130. doi:10.1111/j.1528-1167.2009.02042.x. PMID 19298435.